Overview Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers Status: Completed Trial end date: 2016-08-01 Target enrollment: Participant gender: Summary To evaluate the safety and tolerability of Hepalatide(L47) and characterize the clinical pharmacokinetics in healthy volunteers. Phase: Phase 1 Details Lead Sponsor: Shanghai HEP Pharmaceatical Co., Ltd.